DN
Sumitomo Pharma Co., Ltd.
DNPUF · OTC
$9.79 -2.20% (-$0.22)
1M +5.61%
Market Cap ¥685.8B
P/E Ratio 6.03x
Div. Yield -
ROE 36.17%
Bulios Fair Price
$9.16
6.4% downside
Current Price
$9.79
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DNPUF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
99 /100
Cheap P/E 6.03x
EV/EBITDA 5.97x
P/S 1.44x
Growth
0 /100
Declining EPS growth 25.17%
Rev. growth 10.70%
FCF growth 41.96%
Profitability
76 /100
Strong Gross margin 55.01%
Net margin 23.89%
Op. margin 10.05%
Quality
70 /100
Excellent ROIC 8.16%
ROE 36.17%
ROA 13.57%
Debt
89 /100
Low Debt/Equity 0.39x
Current ratio 1.21x
Int. coverage 14.09x
Stability
24 /100
Unstable Beta 0.45x
Rev. volatility 35.35%
EPS volatility 226.80%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DNPUF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Toru Kimura
Employees
3,123
Headquarters
Osaka
Upcoming events
04 NOV
Earnings
Upcoming earnings report